Capstone Investment Advisors’s 4D Pharma PLC LBPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,200
Closed -$25K 1954
2022
Q2
$25K Hold
15,200
﹤0.01% 1647
2022
Q1
$73K Buy
+15,200
New +$63.5K ﹤0.01% 1872

Capstone Investment Advisors's LBPS Position: Q3 2022 in Review

Capstone Investment Advisors sold out of 4D Pharma PLC (LBPS) in Q3 2022, closing a stake of 15,200 shares — an estimated $25K sold.

Capstone Investment Advisors first reported a position in LBPS in Q1 2022 and held it in 2 quarters. The position peaked at $73K in Q1 2022. 1 fund tracked by Wall St. Rank holds LBPS as of Q3 2022.

  • Capstone Investment Advisors reported no remaining 4D Pharma PLC position as of Q3 2022 after selling out during the quarter.
  • Capstone Investment Advisors sold 15,200 4D Pharma PLC shares in Q3 2022, an estimated $25K.
  • Capstone Investment Advisors first reported a position in 4D Pharma PLC in Q1 2022 and held it in 2 quarters.
  • Capstone Investment Advisors's 4D Pharma PLC position peaked at $73K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held 4D Pharma PLC as of Q3 2022.

Based on Capstone Investment Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.